Enovis Corporation functions as a global medical technology enterprise, specializing in the design, manufacturing, and distribution of advanced medical device solutions. These products are utilized by a broad spectrum of healthcare professionals worldwide, including orthopedic specialists, surgeons, primary care physicians, pain management experts, physical therapists, podiatrists, chiropractors, and athletic trainers. Their offerings are geared towards treating patients suffering from musculoskeletal conditions that arise from degenerative diseases, deformities, traumatic events, or sports-related injuries. The company's extensive portfolio encompasses a variety of products such as rigid and soft orthopedic braces, hot and cold therapy items, bone growth stimulators, vascular therapy systems complemented by compression garments, therapeutic footwear and inserts, electrical stimulators for pain relief, and various physical therapy aids. Additionally, Enovis provides a comprehensive range of reconstructive joint products for crucial areas like the hip, knee, shoulder, elbow, foot, ankle, and fingers. Products are sold through a network of independent distributors, which includes other healthcare professionals, consumer retail stores, and pharmacies, as well as directly to consumers, notably under the DJO brand. The company, formerly known as Colfax Corporation, is headquartered in Wilmington, Delaware.
Subscribe to see Enovis Corporation’s full profile → the full roster, investors in every round, weekly hiring history and every corporate event
Enovis Corporation is a medical devices company headquartered in United States. It is publicly listed (0I1B) with a market capitalisation of $1.5B. Xcout tracks 21 named people at Enovis Corporation, including Damien McDonald (Chief Executive Officer & Director). Xcout recorded 3 job postings from Enovis Corporation in the last 90 days.
15 more named people on record for Enovis Corporation, with roles, board committees and tenure — see the full roster →
Xcout recorded 3 job postings from Enovis Corporation in the last 90 days, from a hiring record Xcout has kept since June 2026.
The weekly hiring trend, the roles and locations behind it — see Enovis Corporation's hiring signals →
A few of Enovis Corporation's closest competitors — see the full list of competitors and alternatives →
DJO is an American medical device manufacturing company headquartered in Lewisville and Dallas, Texas, producing orthopedic products and rehabilitation equipment.
Globus Medical, Inc. is a global medical technology company dedicated to inventing, developing, and marketing a diverse range of healthcare solutions. Their primary focus is on addressing musculoskeletal disorders for patients worldwide. Their extensive portfolio includes a variety of spinal products. These encompass traditional fusion implants like pedicle screw and rod systems, plating systems, intervertebral spacers, and corpectomy devices, all designed to treat conditions such as degenerative diseases, deformities, tumors, and trauma. Furthermore, they offer advanced motion preservation technologies, including dynamic stabilization, total disc replacement, and interspinous distraction devices. The company also provides interventional pain management options for vertebral compression fractures, alongside a selection of regenerative biologic products such as allografts and synthetic alternatives. Beyond spinal care, Globus Medical manufactures solutions for orthopedic trauma, featuring products like fracture plates, compression screws, intramedullary nails, and external fixation systems. They also specialize in hip and knee joint reconstruction, offering modular hip stems, acetabular cups, and various knee arthroplasty implants, including posterior stabilizing and cruciate retaining designs. Additionally, the company engages in the distribution of human cell, tissue, and other cellular and tissue-based products. Established in 2003, Globus Medical, Inc. maintains its corporate headquarters in Audubon, Pennsylvania.
Envista Holdings Corporation is an enterprise dedicated to the development and distribution of a comprehensive range of dental solutions. These offerings are crucial for the identification, therapeutic intervention, and preventative care of diverse oral health issues, specifically addressing the teeth, gingiva (gums), and their supporting bone structures. The company's principal location is in Brea, California, and it maintains a workforce comprising 12,800 full-time personnel. The firm organizes its business activities into two main divisions: "Specialty Products & Technologies" and "Equipment & Consumables." The Specialty Products & Technologies division concentrates on the creation, fabrication, and promotion of sophisticated dental implant systems, advanced prosthetic devices, and their associated digital treatment software and technological advancements. This segment also provides orthodontic remedies, including bracket systems, clear aligners, and various items for dental laboratories. Conversely, the Equipment & Consumables division is responsible for conceptualizing, producing, and bringing to market a wide array of dental apparatus and vital supplies intended for professional dental clinics. This extensive catalog includes digital imaging instruments, specialized software, and visual or magnification systems; patient treatment units and other essential fixtures for dental practices; complete endodontic kits along with their complementary consumable items; materials and tools for restorative dentistry; rotary cutting tools (burs); impression-making compounds; adhesive agents and dental cements; and products designed for infection control.
Orthofix Medical Inc., founded in 1980 and headquartered in Lewisville, Texas, operates as a global medical technology company focusing on devices and biologics. Its reach extends across the United States, several European nations including Italy, Germany, France, and the United Kingdom, as well as Brazil and other international markets. The company's operations are divided into two main segments: Global Spine and Global Orthopedics. Within the Global Spine division, Orthofix is responsible for the development, production, and distribution of bone growth stimulators. These devices are designed to facilitate bone fusion and serve as a therapeutic intervention for fractures located outside the spine and in the limbs. This segment also creates and commercializes a range of motion preservation and fixation implant products utilized in spinal surgical procedures. Furthermore, it supplies physicians with various tissue forms and synthetic-based regenerative biologic solutions to address a wide spectrum of spinal and orthopedic conditions. The Global Orthopedics segment concentrates on the design, development, and commercialization of specialized orthopedic products. These offerings are essential for procedures involving fracture repair, the correction of deformities, and bone reconstruction. Orthofix distributes its products to a diverse clientele, including physicians, hospitals, outpatient surgery centers, and integrated health delivery systems. This is achieved through a comprehensive sales network that includes its own sales force, independent distributors, and both employed and external sales representatives. The company, previously known as Orthofix International N.V., officially changed its name to Orthofix Medical Inc. in July 2018.
Avanos Medical, Inc. is a pioneering medical technology enterprise dedicated to furnishing device solutions across a broad international footprint, encompassing North America, Europe, the Middle East, Africa, the Asia Pacific region, and Latin America. Its comprehensive product array targets two primary areas: chronic care and non-opioid pain management. Within chronic care, the company provides digestive health offerings such as Mic-Key enteral feeding tubes, Corpak patient feeding systems, and NeoMed solutions tailored for neonatal and pediatric patients. Its respiratory health segment includes closed airway suction systems and other airway management devices, marketed under prominent brands like Ballard, Microcuff, and Endoclear. For non-opioid pain relief, Avanos offers acute pain solutions, including On-Q and ambIT surgical pain pumps, along with Game Ready cold and compression therapy systems. It also features interventional pain solutions, providing minimally invasive therapies like Coolief for long-term pain alleviation. The company facilitates product access by selling directly to hospitals, various healthcare providers, and end-user facilities, in addition to utilizing third-party wholesale distributors. Originally incorporated in 2014 and known as Halyard Health, Inc., the company officially adopted the name Avanos Medical, Inc. in June 2018 and maintains its headquarters in Alpharetta, Georgia.
Encore Medical Inc. is a U.S.-based medical technology enterprise. Operating from its headquarters in Eagan, Minnesota, the company is dedicated to designing, producing, and distributing advanced, specialized devices for both healthcare providers and patients. These innovative tools are utilized in diverse settings, from professional clinics to private homes. Encore Medical's stock is publicly traded on the NYSE Arca exchange, under the ticker symbol EMI.
Funding rounds, acquisitions, new executives, launches and expansions, each with a two-line summary and a link to the source. One short email a day, only when there is news.
Free: up to 5 companies, daily. Subscribers also follow whole sectors and saved filters (M&A in Israel, AI funding…), get instant alerts, in-app notifications and signed webhooks, and open the full profile behind every name. Subscribe →
Post the link and the card appears automatically — each network fetches the image itself.